These results suggest that an adverse prognostic effect of MKI67 in breast cancer metastasis is co-regulated by other complex mechanisms besides Grhl2-mediation, or is triggered in different stages between tumorigenesis and metastasis. This evidence concerns the gene GRHL2 and breast carcinoma.